Abstract
Cancers are heterogeneous and genetically unstable. New methods are needed that provide the sensitivity and specificity to query single cells at the genetic loci that drive cancer progression, thereby enabling researchers to study the progression of individual tumors. Here, we report the development and application of a bead-based hemi-nested microfluidic droplet digital PCR (dPCR) technology to achieve 'quantitative' measurement and single-molecule sequencing of somatically acquired carcinogenic translocations at extremely low levels (
Original language | English |
---|---|
Pages (from-to) | e159 |
Number of pages | 1 |
Journal | Nucleic Acids Research |
Volume | 41 |
Issue number | 16 |
DOIs | |
Publication status | Published - 2013 |